Daniel N. Egan

1 article listing Daniel N. Egan in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence Nature Communications